Comparison the effect of Olanzapine and Haloperidol on the treatment of delirium in ICU in Valiasr hospital
Phase 2
Recruiting
- Conditions
- Delirium.Delirium due to known physiological condition
- Registration Number
- IRCT20141209020258N114
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Delirium detection
Age older than 18 years
No pregnancy and breastfeeding
Insensitivity to Olanzapine and Haloperidol
Absence of QTC is greater than 440 milliseconds
Absence of a neurological disease such as stroke, dementia, psychosis
Having a urine catheter
Lack of mental disorder or disability disorder pre-admission
Exclusion Criteria
Patients who have more than 24 hours of coma and have a structural reason for their low level of consciousness.
Dissatisfaction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation. Timepoint: Every 8 hours. Method of measurement: Richmond agitation and sedation scale.;Illness severity. Timepoint: In first and third day after the intervention. Method of measurement: APACHE II score.
- Secondary Outcome Measures
Name Time Method